ROCHE FDA Approval NDA 020813

NDA 020813

ROCHE

FDA Drug Application

Application #020813

Documents

Letter2010-09-21
Letter2010-09-21
Letter2013-11-06
Label2009-05-12
Label2010-09-07
Letter2009-05-01
Letter2011-12-05
Label2010-09-07
Label2013-11-01
Label2016-12-20
Letter2016-12-22
Medication Guide2016-12-30

Application Sponsors

NDA 020813ROCHE

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued005

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1KLONOPIN RAPIDLY DISINTEGRATINGCLONAZEPAM
002TABLET, ORALLY DISINTEGRATING;ORAL0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1KLONOPIN RAPIDLY DISINTEGRATINGCLONAZEPAM
003TABLET, ORALLY DISINTEGRATING;ORAL0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1KLONOPIN RAPIDLY DISINTEGRATINGCLONAZEPAM
004TABLET, ORALLY DISINTEGRATING;ORAL1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1KLONOPIN RAPIDLY DISINTEGRATINGCLONAZEPAM
005TABLET, ORALLY DISINTEGRATING;ORAL2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1KLONOPIN RAPIDLY DISINTEGRATINGCLONAZEPAM

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1997-12-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2001-12-03STANDARD
LABELING; LabelingSUPPL5AP2009-04-23901 REQUIRED
LABELING; LabelingSUPPL6AP2010-09-01STANDARD
LABELING; LabelingSUPPL7AP2010-09-01STANDARD
REMS; REMSSUPPL8AP2011-11-29N/A
LABELING; LabelingSUPPL9AP2013-10-31STANDARD
LABELING; LabelingSUPPL10AP2016-12-16STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL6Null7
SUPPL7Null31
SUPPL8Null6
SUPPL9Null6
SUPPL10Null7

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20813
            [companyName] => ROCHE
            [docInserts] => ["Medication Guide","http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/017533s058lbl.pdf#page=20"]
            [products] => [{"drugName":"KLONOPIN RAPIDLY DISINTEGRATING","activeIngredients":"CLONAZEPAM","strength":"0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"KLONOPIN RAPIDLY DISINTEGRATING","activeIngredients":"CLONAZEPAM","strength":"0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"KLONOPIN RAPIDLY DISINTEGRATING","activeIngredients":"CLONAZEPAM","strength":"0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"KLONOPIN RAPIDLY DISINTEGRATING","activeIngredients":"CLONAZEPAM","strength":"1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"KLONOPIN RAPIDLY DISINTEGRATING","activeIngredients":"CLONAZEPAM","strength":"2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"12\/16\/2016","submission":"SUPPL-10","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020813s010lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020813s010lbl.pdf\"}]","notes":""},{"actionDate":"10\/31\/2013","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/017533s053,020813s009lbl.pdf\"}]","notes":""},{"actionDate":"09\/01\/2010","submission":"SUPPL-7","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/017533s046s048,020813s006s007lbl.pdf\"}]","notes":""},{"actionDate":"09\/01\/2010","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/017533s046s048,020813s006s007lbl.pdf\"}]","notes":""},{"actionDate":"09\/01\/2010","submission":"SUPPL-6","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/017533s046s048,020813s006s007lbl.pdf\"}]","notes":""},{"actionDate":"04\/23\/2009","submission":"SUPPL-5","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/017533s045,020813s005lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"KLONOPIN RAPIDLY DISINTEGRATING","submission":"CLONAZEPAM","actionType":"0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"KLONOPIN RAPIDLY DISINTEGRATING","submission":"CLONAZEPAM","actionType":"0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"KLONOPIN RAPIDLY DISINTEGRATING","submission":"CLONAZEPAM","actionType":"0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"KLONOPIN RAPIDLY DISINTEGRATING","submission":"CLONAZEPAM","actionType":"1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"KLONOPIN RAPIDLY DISINTEGRATING","submission":"CLONAZEPAM","actionType":"2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2016-12-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.